NCT01485068View on ClinicalTrials.gov

Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in In-Stent Restenosis Lesions (DEBREST)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2014

Conditions

In-stent Coronary Artery Restenosis

Interventions

DEVICE

Danubio paclitaxel-eluting balloon

Inflation of the Danubio Paclitaxel Eluting Balloon in in-stent restenosis lesions.

Trial Locations (8)

14050

Centre Hospitalier privé Saint-Martin, Caen

30000

Les Franciscaines, Nîmes

33600

Clinique Saint-Martin, Pessac

66012

Clinique Saint-Pierre, Perpignan

67504

Centre Hospitalier d'Haguenau, Haguenau

78740

Centre cardiologique d'Evecquemont, Évecquemont

83192

Polyclinique les Fleurs, Ollioules

92160

Hôpital Privé d'Antony, Antony

All Listed Sponsors

collaborator

European Cardiovascular Research Center

NETWORK

lead

MINVASYS

INDUSTRY

NCT01485068 - Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in In-Stent Restenosis Lesions (DEBREST) | Biotech Hunter | Biotech Hunter